Showing results (51-60 of 113) with videos related to
Sort By:
Pageof 12
AIDS (London, England)|January 26, 2018
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVNikki Mulligan, Brookie M Best, Jiajia Wang, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2011
Atazanavir pharmacokinetics with and without tenofovir during pregnancyMark Mirochnick, Brookie M Best, Alice M Stek, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 8, 2015
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected WomenAlice Stek, Brookie M Best, Jiajia Wang, et al.Journal of Clinical Pharmacology|September 7, 2019
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and AcyclovirXiaomei I Liu, Jeremiah D Momper, Natella Rakhmanina, et al.AIDS (London, England)|February 14, 2006
Impact of pregnancy on abacavir pharmacokineticsBrookie M Best, Mark Mirochnick, Edmund V Capparelli, et al.AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.Antimicrobial Agents and Chemotherapy|February 25, 2009
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai womenTim R Cressey, Russell Van Dyke, Gonzague Jourdain, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2008
Nevirapine concentrations in newborns receiving an extended prophylactic regimenMark Mirochnick, Karin Nielsen-Saines, Jose Henrique Pilotto, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2022
Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) ExposureAgathe Béranger, Adrie Bekker, Belén P Solans, et al.The Journal of Antimicrobial Chemotherapy|September 28, 2014
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancyTim R Cressey, Saik Urien, Edmund V Capparelli, et al.Pageof 12